ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.

Vander Lugt, Mark T

ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death. [electronic resource] - The New England journal of medicine Aug 2013 - 529-39 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1533-4406

10.1056/NEJMoa1213299 doi


Biomarkers--blood
Graft vs Host Disease--blood
Hematopoietic Stem Cell Transplantation--adverse effects
Humans
Interleukin-1 Receptor-Like 1 Protein
Middle Aged
Receptors, Cell Surface--blood
Recurrence
Risk Assessment--methods
Risk Factors
Transplantation, Homologous